Role of the specific inhibitor of 5-lipoxygenase-activating protein MK886 in inhibiting alcoholic liver disease in mice

Yang ShuJuan; Guo YaLing; Fu Shan; He YingLi; Zhao YingRen; Tian Zhen

doi:10.3969/j.issn.1001-5256.2019.08.028

Volume 35 Issue 8

Aug. 2019

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2019 > 35(8): 1791-1796

PDF( 2715 KB)

Role of the specific inhibitor of 5-lipoxygenase-activating protein MK886 in inhibiting alcoholic liver disease in mice

DOI: 10.3969/j.issn.1001-5256.2019.08.028

Department of Infectious Diseases, The First Affiliated Hospital of Xi'an Jiaotong University

Research funding:

Received Date: 2019-03-19
Published Date: 2019-08-20

Abstract

Abstract

Objective To investigate the effect of MK886, a specific inhibitor of 5-lipoxygenase-activating protein (FLAP) , on alcoholic liver disease (ALD) in mice. Methods A total of 48 male Kunming mice were randomly divided into ALD group, ALD/MK886 group, control group, and normal group. The mice in the ALD group and the ALD/MK886 group were fed with Tipoe-Nanji alcohol liquid diet and were given alcohol by gavage 6 weeks later to establish a model of acute ALD. The mice in the control group were given control diet without alcohol, and those in the normal group were given normal diet. After 2 days of alcohol intake, the mice in the ALD/MK886 group were given intraperitoneally injected MK886 (0. 01 mg/10 g) once a day. The mice were sacrificed at 9 hours after the administration of alcohol by gavage. Serum levels of aspartate aminotransferase (AST) , alanine aminotransferase (ALT) , lactate dehydrogenase (LDH) , and triglyceride (TG) and the levels of TG and malondialdehyde (MDA) in liver tissue were measured. HE staining was performed for liver tissue and pathological score was determined. Western blot was used to measure the expression of FLAP and 5-lipoxygenase (5-LO) in liver tissue and Thp-1 cells, and flow cytometry was used to measure the apoptosis of Thp-1 cells. One-way ANOVA was used for comparison between groups; the least significant difference t-test was used for comparison of data with homogeneity of variance, and the Tamhane's T2 test was used for comparison of data with heterogeneity of variance. Results The ALD group and the ALD/MK886 group had a reduction in body weight within the first week of modeling, followed by a gradual increase; at the end of modeling, the ALD group had significantly lower bodyweight and liver index than the normal group and the control group (all P < 0. 05) , and the ALD/MK886 group had significantly higher body weight and liver index than the ALD group (both P < 0. 05) . Compared with the normal group and the control group, the ALD group had significant increases in the levels of AST, ALT, LDH, and TG in serum and the levels of TG and MDA in liver tissue (all P < 0. 05) , and compared with the ALD group, the ALD/MK886 group had significant reductions in the above indices (all P < 0. 05) . The ALD group had a significantly higher score of hepatic steatosis than the normal group and the control group (both P < 0. 05) , and compared with the ALD group, the ALD/MK886 group had a significant reduction in this score (P < 0. 05) . Compared with the normal group and the control group, the ALD group had significant increases in the expression of 5-LO and FLAP in the liver (all P < 0. 05) , and the ALD/MK886 group had significant reductions compared with the ALD group (P < 0. 05) . Lipopolysaccharide (LPS) upregulated the expression of FLAP and 5-LO in Thp-1 cells, and MK886 alleviated such effect of LPS (all P < 0. 05) ; MK886 promoted the apoptosis of Thp-1 cells, and LPS alleviated the effect of MK886 in promoting cell apoptosis (all P < 0. 01) . Conclusion MK886 can inhibit the expression of 5-LO, induce the apoptosis of Kupffer cells, and thus exert a therapeutic effect on ALD in mice.
- liver diseases, alcoholic,
- lipoxygenase,
- kupffer cell,
- apoptosis,
- mice, inbred C57BL

FullText(HTML)

References(21)

References

[1] OSNA NA, DONOHUE TM Jr, KHARBANDA KK. Alcoholic liver disease:Pathogenesis and current management[J]. Alcohol Res, 2017, 38 (2) :147-161.

[2] VASSALLO GA, TARLI C, RANDO MM, et a. Liver transplantation in patients with alcoholic liver disease:A retrospective study[J]. Alcohol Alcohol, 2018, 53 (2) :151-156.

[3] National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association;Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for alcoholic liver disease:A 2018 update[J]. J Clin Hepatol, 2018, 34 (5) :939-946. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会.酒精性肝病防治指南 (2018年更新版) [J].临床肝胆病杂志, 2018, 34 (5) :939-946.

[4] STICKEL F, DATZ C, HAMPE J, et al. Pathophysiology and management of alcoholic liver disease:Update 2016[J]. Gut Liver, 2017, 11 (2) :173-188.

[5] KOLIOS G, VALATAS V, KOUROUMALIS E. Role of Kupffer cells in the pathogenesis of liver disease[J]. World J Gastroenterol, 2006, 12 (46) :7413-7420.

[6] BALA S, CSAK T, KODYS K, et al. Alcohol-induced miR-155 and HDAC11 inhibit negative regulators of the TLR4 pathway and lead to increased LPS responsiveness of Kupffer cells in alcoholic liver disease[J]. J Leukoc Biol, 2017, 102 (2) :487-498.

[7] PARK JK, SHAO M, KIM MY, et al. An endoplasmic reticulum protein, Nogo-B, facilitates alcoholic liver disease through regulation of kupffer cell polarization[J]. Hepatology, 2017, 65 (5) :1720-1734.

[8] SORGI CA, ZARINI S, MARTIN SA, et al. Dormant 5-lipoxygenase in inflammatory macrophages is triggered by exogenous arachidonic acid[J]. Sci Rep, 2017, 7 (1) :10981.

[9] BRUNO F, ERRICO S, PACE S, et al. Structural insight into the optimization of ethyl 5-hydroxybenzo[g]indol-3-carboxylates and their bioisosteric analogues as 5-LO/m-PGES-1 dual inhibitors able to suppress inflammation[J]. Eur J Med Chem, 2018, 155:946-960.

[10] TITOS E, CLRIA J, PLANAGUMA, et al. Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury:Role of Kupffer cells[J]. J Leukoc Biol, 2005, 78 (4) :871-878.

[11] LEO LM, ALMEIDA-CORRA S, CANETTI CA, et al. Agedependent relevance of endogenous 5-lipoxygenase derivatives in anxiety-like behavior in mice[J]. PLo S One, 2014, 9 (1) :e85009.

[12] SUMMA KC, VOIGT RM, FORSYTH CB, et al. Disruption of the circadian clock in mice increases intestinal permeability and promotes alcohol-induced hepatic pathology and inflammation[J]. PLo S One, 2013, 8 (6) :e67102.

[13] DESMET VJ, KNODELL RG, ISHAK KG, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis[Hepatology 1981; 1:431-435][J]. J Hepatol, 2003, 38 (4) :382-386.

[14] MASARONE M, ROSATO V, DALLIO M, et al. Epidemiology and natural history of alcoholic liver disease[J]. Rev Recent Clin Trials, 2016, 11 (3) :167-174.

[15] LOUVET A, MATHURIN P. Alcoholic liver disease:Mechanisms of injury and targeted treatment[J]. Nat Rev Gastroenterol Hepatol, 2015, 12 (4) :231-242.

[16] SZABO G, PETRASEK J. Gut-liver axis and sterile signals in the development of alcoholic liver disease[J]. Alcohol Alcohol, 2017, 52 (4) :414-424.

[17] LIN XX, CHEN D, ZHAO Q, et al. Genetic reasearch on the incidence of alcoholic liver disease[J]. Chin J Clin Pharmacol Ther, 2017, 22 (11) :1309-1314. (in Chinese) 林秀贤, 陈丹, 赵青, 等.影响酒精性肝病发病的遗传学研究进展[J].中国临床药理学与治疗学, 2017, 22 (11) :1309-1314.

[18] NADARAJAN K, BALARAM P, KHOO BY. MK886 inhibits the pioglitazone-induced anti-invasion of MDA-MB-231 cells is associated with PPARα/γ, FGF4 and 5LOX[J]. Cytotechnology, 2016, 68 (5) :1771-1787.

[19] DAGLAR GO, KAMA NA, ATLI M, et al. Effect of 5-lipoxygenase inhibition on Kupffer cell clearance capacity in obstructive jaundiced rats[J]. J Surg Res, 2001, 96 (2) :158-162.

[20] ZHOU H, YU M, ZHAO J, et al. IRAKM-Mincle axis links cell death to inflammation:Pathophysiological implications for chronic alcoholic liver disease[J]. Hepatology, 2016, 64 (6) :1978-1993.

[21] KOOP DR, KLOPFENSTEIN B, IIMURO Y, et al. Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite the induction of CYP2E1[J]. Mol Pharmacol, 1997, 51 (6) :944-950.

Relative Articles

[1]	Yanhong BAO, Qiang WANG, Wenlong ZHANG, Na GE, Nan LI, Jun SU, Kexin LI. Ursolic acid in Hippophae rhamnoides L. inhibits hepatocyte apoptosis in rats with alcoholic liver disease by regulating mitochondria-cytochrome c[J]. Journal of Clinical Hepatology, 2023, 39(7): 1617-1626. doi: 10.3969/j.issn.1001-5256.2023.07.016
[2]	Ruibin WANG, Yuzheng LU, Jinglin ZHU, Wei WANG, Guang JIA. Inhibitory effect of lidocaine on Kupffer cell inflammatory response and its effect on liver abscess formation in diabetic mice[J]. Journal of Clinical Hepatology, 2022, 38(6): 1341-1346. doi: 10.3969/j.issn.1001-5256.2022.06.023
[3]	Jianan ZHAO, Jinghua PENG, Ping LIU, Yiyang HU. Effect of Cordyceps polysaccharides on hepatocyte apoptosis induced by tumor necrosis factor-α[J]. Journal of Clinical Hepatology, 2021, 37(6): 1368-1372. doi: 10.3969/j.issn.1001-5256.2021.06.029
[4]	Bi YanZhen, Zhang QiuSheng, Fan Zeng, Yang YongHong, Zhang XiaoBei, Wang QuanQuan, Wang QuanYi, Wang YiBo, Duan ZhongPing, Chen Yu, Shu ZhenFeng, Si ChuanPing, Hong Feng. Effect of human liver-derived stem cells in prevention and treatment of alcoholic fatty liver disease in mice[J]. Journal of Clinical Hepatology, 2019, 35(3): 592-595. doi: 10.3969/j.issn.1001-5256.2019.03.027
[5]	Gong Jing, Jie XinKe. Effect of endoplasmic reticulum stress and autophagy on hepatocyte apoptosis[J]. Journal of Clinical Hepatology, 2019, 35(12): 2828-2832. doi: 10.3969/j.issn.1001-5256.2019.12.041
[6]	Pan Jing, Pan WenTing, Wu LiHui. Expression and significance of Th22 cells and its functional factor interleukin-22 in mice with autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2018, 34(8): 1745-1749. doi: 10.3969/j.issn.1001-5256.2018.08.030
[7]	Gao Si, Zhao XiangXuan, Lu ZaiMing. Role of cell apoptosis regulated by P53 in treatment of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2017, 33(7): 1373-1376. doi: 10.3969/j.issn.1001-5256.2017.07.038
[8]	Zhang ChaoYa, Zhao XiangXuan, Lu ZaiMing, Guo QiYong. Research advances in sorafenib- induced apoptotic signaling pathways in liver cancer cells[J]. Journal of Clinical Hepatology, 2016, 32(4): 816-820. doi: 10.3969/j.issn.1001-5256.2016.04.048
[9]	Pan LiuLan, Jia ShengNan, Ma JingTing, Tai JingHua, Jin ZhenJing. Effect of decoy receptor 3 gene on hepatocyte apoptosis[J]. Journal of Clinical Hepatology, 2016, 32(7): 1330-1333. doi: 10.3969/j.issn.1001-5256.2016.07.023
[10]	Zhang Xu, Wang Yu, Ma Juan, Wang ZhenZhen, Yuan Juan, Ma Yan, Liu Xin. Role of endoplasmic reticulum stress-mediated apoptosis in liver fibrosis[J]. Journal of Clinical Hepatology, 2015, 31(9): 1537-1539. doi: 10.3969/j.issn.1001-5256.2015.09.044
[11]	Peng Yuan, Tao YanYan, Huang Kai, Zhao Qiang, Liu ChengHai. Regulatory effect of poly I∶C on intrahepatic natural killer cells in mouse model of liver injury induced by carbon tetrachloride[J]. Journal of Clinical Hepatology, 2015, 31(12): 2077-2083. doi: 10.3969/j.issn.1001-5256.2015.12.022
[12]	Pan YuanWei, Ping Jian, Xu LieMing. Research advances in main signaling pathways for inducing apoptosis of activated hepatic stellate cells[J]. Journal of Clinical Hepatology, 2014, 30(2): 182-185. doi: 10.3969/j.issn.1001-5256.2014.02.021
[13]	Wang XiXun, Jiang LiXin, Wang JingLin, Liang Jing, Zhai HuiYuan, Xia XianMing. Experimental study on hepatocyte apoptosis induced by acute biliary tract infection[J]. Journal of Clinical Hepatology, 2014, 30(11): 1164-1168. doi: 10.3969/j.issn.1001-5256.2014.11.018
[14]	Weng ShanGeng, Xu ChangGuo, Sun Ying, Shi Zheng, Lin LiJuan. Study on the apoptosis of rat hepatic stellate cells induced by kapamycin[J]. Journal of Clinical Hepatology, 2012, 28(3): 219-222.
[15]	Qiao ChunPing, Chen YueXiang. Advances in study of the relationship between apoptosis and alcoholic liver disease[J]. Journal of Clinical Hepatology, 2012, 28(5): 386-390.
[16]	Zhang LiLi, Guo XiaoHong, Liu LiXin, Zhang QianQian. IGFBPrP1 siRNA induced apoptosis in rat hepatic stellate cells and its mechanism[J]. Journal of Clinical Hepatology, 2011, 27(9): 965-969+979.
[17]	Zhang Biao, Sui Tao, Yu XiuYing, Cao YongXian, Yao Yuan, He Hong. Significance of detecting apoptosis of PBMC and cytokine of supernatant induced by PHA in chronic hepatitis B[J]. Journal of Clinical Hepatology, 2004, 20(3): 138-140.

Supplements(0)

Cited By

Cited by

Periodical cited type(2)

1.	林海珠，卢柯羽，杨洋. 5-LOX及其抑制剂对肿瘤影响的研究进展. 中国肿瘤生物治疗杂志. 2024(05): 514-518 .
2.	张芬，罗新军，张贞鲁. 茵栀黄颗粒联合水飞蓟宾胶囊对酒精性肝病患者临床疗效及肝功相关指标的影响分析. 贵州医药. 2020(12): 1958-1959 .

Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (1437) PDF downloads(241)

Role of the specific inhibitor of 5-lipoxygenase-activating protein MK886 in inhibiting alcoholic liver disease in mice

DOI: 10.3969/j.issn.1001-5256.2019.08.028